$JNJ Recent News Apple as the Comeback Kid 1:13 p.m.

New Post Public Reply Private Reply Replies (0) Message Board

Mar 17, 2014 at 10:50 AM

$JNJ Recent News

Apple as the Comeback Kid 1:13 p.m. March 13, 2014 - Mark Hulbert
The well is running dry for big oil 6:00 a.m. March 3, 2014 - Jeff Reeves
West Coast Asset Management’s top holdings 12:29 p.m. Feb. 28, 2014 - Insider Monkey
Best stocks for legalized marijuana 1:37 p.m. Feb. 27, 2014 - blogs.marketwatch.com
Billionaire Stan Druckenmiller's recent moves 11:50 a.m. Feb. 24, 2014 - Insider Monkey
You'd have to be a dope to buy marijuana stocks 1:36 p.m. Feb. 13, 2014 - blogs.marketwatch.com
FDA approval of leukemia treatment boosts shares of Pharmacyclics 1:57 p.m. Feb. 12, 2014 - blogs.marketwatch.com
Goldman: The 4 biggest themes of earnings season 8:06 a.m. Feb. 12, 2014 - blogs.marketwatch.com
10 stocks to beat a declining market 3:01 p.m. Feb. 7, 2014 - Mark Hulbert
Feds, pharma rivals team up on Alzheimer's 2:32 p.m. Feb. 6, 2014 - blogs.marketwatch.com
CVS move won’t slow e-cigarette sales 4:42 p.m. Feb. 5, 2014 - Jonnelle Marte
Newscast: Stocks mixed to start short week 6:32 p.m. Jan. 21, 2014 - MarketWatch
U.S. stocks close higher; earnings misses drag on Dow 4:51 p.m. Jan. 21, 2014 - Anora Mahmudova
Newscast: Stocks open week mixed 4:32 p.m. Jan. 21, 2014 - MarketWatch
Nasdaq nabs 13-year high, but Dow slips: stock market live blog recap 4:05 p.m. Jan. 21, 2014 - blogs.marketwatch.com
Ken Fisher's new top stock picks 2:48 p.m. Jan. 21, 2014 - Insider Monkey
Johnson & Johnson shares take a hit on full-year outlook 11:27 a.m. Jan. 21, 2014 - blogs.marketwatch.com
Newscast: Demand soars for humanely-raised pork 10:00 a.m. Jan. 21, 2014 - MarketWatch
Johnson & Johnson’s profit jumps 37% 9:49 a.m. Jan. 21, 2014 - Tess Stynes
Stock futures rise after China’s cash injections 9:32 a.m. Jan. 21, 2014 - Barbara Kollmeyer

Rich And Retired? It Is ALL About Capital Preservation, Folks! 8:24 a.m. March 16, 2014 - Seeking Alpha
Dividend Champions: 14 Increases Expected By The End Of May 5:00 p.m. March 15, 2014 - Seeking Alpha
J&J Lawsuit Sheds Light on Link Between Doctors and Device Makers 4:43 p.m. March 14, 2014 - Wall St. Cheat Sheet
Johnson & Johnson Rolls Out New Products, Dividends 4:16 p.m. March 14, 2014 - Investors Business Daily
Blue Light Specials In The Market: Healthcare 2:12 p.m. March 14, 2014 - Seeking Alpha
Stock Market News for March 14, 2014 - Market News 10:06 a.m. March 14, 2014 - Zacks.com
Lawsuit highlights close ties between doctors and device manufacturers 8:13 a.m. March 14, 2014 - Seeking Alpha
Jefferies’ Cheapest Health Care Stocks to Buy 7:54 a.m. March 14, 2014 - 247WallSt.com
Doctors, Device Makers: Close Ties 7:06 p.m. March 13, 2014 - The Wall Street Journal Interactive Edition
Debunking The 'Dividends Don't Add Shareholder Value' Myth 3:56 p.m. March 13, 2014 - Seeking Alpha
Rich And Retired? Please Buy Dividend Stocks 2:17 p.m. March 13, 2014 - Seeking Alpha
Dividend Stocks vs. Dividend ETFs 12:30 p.m. March 12, 2014 - GuruFocus.com
CA panel deems Sovaldi a "low value" treatment 11:50 a.m. March 12, 2014 - Seeking Alpha
Gilead Sciences' Novel Leukemia Drug Should Extend Company Profits 4:47 p.m. March 11, 2014 - Seeking Alpha
J&J Partners With Biotech Startup Alector to Develop New Alzheimer’s Therapies 3:58 p.m. March 11, 2014 - Wall St. Cheat Sheet
Beware of Getting High on Marijuana Stocks 2:27 p.m. March 11, 2014 - TheStreet.com
Consumer Staple Dividend Analysis 1:25 p.m. March 11, 2014 - Seeking Alpha
Stock Market News for March 11, 2014 - Market News 10:06 a.m. March 11, 2014 - Zacks.com
Big Pharma lobbies Australia to extend poppy growing 9:24 a.m. March 11, 2014 - Seeking Alpha
How To Get The Most Out Of Dividend Growth 8:41 a.m. March 11, 2014 - Seeking Alpha

Critical Alerts For Comcast, Johnson and Johnson, AIG, ARM Holdings, and ConocoPhillips Released By InvestorsObserver 9:31 a.m. Today - PR Newswire - PRF
Philadelphia Jury Awards $3 Million in Topamax Birth Defect Trial 12:44 p.m. March 14, 2014 - PR Newswire - PRF
Spend Management Industry Flocks to NextLevel 2014 9:02 a.m. March 12, 2014 - BusinessWire - BZX
Collaborations, Treatment Approvals, New Solutions, Clinical Trial Results, and New Drug Applications - Analyst Notes on Biogen Idec, Johnson & Johnson, Express Scripts, Merck, and Forest Laboratories 8:00 a.m. March 12, 2014 - PR Newswire - PRF
Johnson & Johnson to Host Analyst Conference Call on First-Quarter Results 4:15 p.m. March 11, 2014 - PR Newswire - PRF
Risperdal Lawsuit in Montana Ends in $5.9 Million Settlement, Bernstein Liebhard LLP Reports 11:50 a.m. March 10, 2014 - PR Newswire - PRF
e-Nicotine Technology to Bring Electronic Nicotine Delivery Products to Market to Address Key Unmet Needs for Smokers and the Public Health Community 10:09 a.m. March 10, 2014 - BusinessWire - BZX
Alector Teams Up with Johnson & Johnson Innovation to Explore Novel Alzheimer's Target 8:00 a.m. March 10, 2014 - PR Newswire - PRF
Simmons Law Firm Reports: Philadelphia Jury Rules Johnson & Johnson Subsidiary Must Pay $3 Million For Child's Birth Injuries 7:45 a.m. March 10, 2014 - PR Newswire - PRF
Pharma-Biotech Industry Helps Drive $14.4 Billion Industrial Project Activity in Massachusetts, an Industrial Info News Alert 6:30 a.m. March 10, 2014 - Marketwire
Johnson & Johnson Launches "Champions of Care" Program in the U.S as Part of 2014 FIFA World Cup™ Sponsorship 1:52 p.m. March 6, 2014 - PR Newswire - PRF
Top Advertising Firm Deutsch Leverages Dot Hill AssuredSAN Arrays to Replicate Data From New York to Los Angeles 9:24 a.m. March 6, 2014 - GlobeNewswire
Mindflash Used to Deliver 1 Million Online Training Courses in 2013 7:30 a.m. March 6, 2014 - Marketwire
BioClinica European User Conference Reflects Expansion Trend In Europe 8:48 a.m. March 5, 2014 - PR Newswire - PRF
Synta Announces Executive Management Changes, Appoints Dr. Paul A. Friedman Director 4:01 p.m. March 3, 2014 - BusinessWire - BZX
Risperdal Lawsuit News: Arkansas Supreme Court Hears Johnson & Johnson Appeal of $1.2 Billion Risperdal Verdict, Bernstein Liebhard LLP Reports. 11:31 a.m. Feb. 28, 2014 - PR Newswire - PRF
Voce Capital Responds to ConMed Board Changes 5:16 p.m. Feb. 27, 2014 - BusinessWire - BZX
Translational Regenerative Medicine: Market Prospects 2014-2024 11:35 a.m. Feb. 27, 2014 - PR Newswire - PRF
Dr. Martin Madaus to be Named Chairman and CEO of Ortho-Clinical Diagnostics (OCD) 11:00 a.m. Feb. 27, 2014 - BusinessWire - BZX
Biosense Webster Receives FDA Approval for First Catheter Ablation Therapy in the U.S. to Feature Direct Contact Force Technology for Treatment of Atrial Fibrillation 6:26 p.m. Feb. 25, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aurra Markets Wins 'Most Transparent Broker' Award 2026

Spotlight on Transparency in Trading Alright, so Aurra Markets snagged the 'Most Transparent Broker' award at the Money Expo in Mumbai this year. From the greasy streets of trading floors to the polished halls of Jio World Convention Centre, transparency is one of those golden words you hear tossed around, but like finding a needle in a haystack, it’s not always easy to...

LITEON Bets Big on Liquid Cooling with DCX Stake

Liquid Cooling: The AI Data Center Game Changer Alright, here's a twist in the tech saga that even a crusty old trader like me finds intriguing. LITEON (2301.TW) has made a bold move investing in DCX Liquid Cooling Systems with a $176 million deal for 25% equity. We're talking about liquid cooling here—it's the magic ingredient when your AI and HPC data centers start...

Ares Management Heads to Barclays Conference Spotlight

All Eyes on Ares – From the Trading Floor to Barclays Nothing like the crisp snap of traders' attention when big players like Ares Management Corporation (NYSE:ARES) are set to spill some beans at a fancy conference. Come September 16, 2026, Ares' head honcho, Michael Arougheti, will be hitting the stage at the Barclays Global Financial Services Conference. It’s the...

Curaleaf Eyes Growth: Conference Signals Opportunities

Curaleaf's Strategic Move: Getting in Front of Investors Here comes Curaleaf Holdings, stepping into the spotlight with their eye on increasing investor engagement. Announcing their participation in the ATB Cormark Capital Markets 2026 Fall Institutional Investor Conference, the folks at Curaleaf aren't just talking—they're putting their top brass under the lights. You...

Navimow's H5 Pro Mower Marries Tech with Nature Care

Garden Tech Reinvented: Enter the H5 Pro Mower Welcome to the 21st-century garden, where robotic ingenuity meets a genuine regard for nature. Folks, the Navimow H5 Pro just rolled onto the scene and it’s tearing up the old playbook of garden maintenance. It’s like blending Silicon Valley tech with Jane Goodall’s wildlife sensibilities. We're talking zero-edge...

Joseph Spine Opens New Regenerative Therapy Center

Regenerative Medicine: A New Frontier in Spine Care When spine care gets a facelift, you take notice. Joseph Spine Institute, a heavyweight in the spine care game, just threw hat into the regenerative ring. We're talking about using a patient's own cells to mend what's broken—that's advanced. They're launching a Regenerative Therapy Center in Tampa, ready to offer these...

Eosera Defies Odds with Texas-Made Ear Care Dominance

Who would've thought an ear care outfit outta Fort Worth could snag a spot on the Inc. 5000 list for six years running? That's right, eosera® is hanging tough, even while the industry's been in a tailspin and tariffs have been squeezing everyone’s margins. Pushing Through Tough Terrain The ear care sector isn't exactly the first place investors look for a splash,...

Perspecta's Study Reveals Troubling Data Accuracy Gaps

Data Accuracy in Healthcare: A Persistent Problem Just when you think data's about numbers and cold, hard facts, healthcare jolts you awake. Perspecta's fresh insights onto provider data accuracy aren't just a snooze fest of statistics but a genuine wake-up call. This report peels open a can of worms some might prefer to ignore. With only half of provider data accurate,...

Nasdaq Flashes Warning Signs for Scage Future's Compliance

Two Strikes from Nasdaq: A Wake-Up Call? Scage Future's getting a double-shot of reality from Nasdaq after slipping under crucial thresholds. Here's the score: Scage's been dinged on their Market Value of Listed Securities (MVLS) and Market Value of Publicly Held Shares (MVPHS). Over a stretch from mid-July to late August, these benchmarks floundered below the line. The...

Alcatraz AI: A Silent Titan in Data Center Security

Why Alcatraz AI is the Security of Choice Forget flashy press releases and splashy marketing campaigns. Alcatraz AI, a company operating out of the hustle and bustle of Cupertino, has managed to quietly dominate a key sector without many folks being the wiser. What's their claim to fame, you ask? They're the chosen gatekeepers for over half of the hyperscale data centers...